Skip to
  1. Homepage
  2. Research and trials
  3. Research projects
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

41 matching term(s)

Funded by an IRDiRC member =

    • CANADA
    • Ontario
    • OTTAWA
    • Funded by an IRDiRC member
    • Differential role of myogenic regulatory factors in establishing muscle-specific gene expression
    • Ottawa Hospital Research Institute
    • Sprott Center for Stem Cell Research
    • More details
    • CANADA
    • Ontario
    • OTTAWA
    • Funded by an IRDiRC member
    • Satellite Stem Cells from Skeletal Muscle for the Treatment of Neuromuscular Disease
    • Ottawa Hospital Research Institute
    • Sprott Center for Stem Cell Research
    • More details
    • CANADA
    • Ontario
    • OTTAWA, ONTARIO
    • Funded by an IRDiRC member
    • SIX family transcription factors in adult muscle regeneration.
    • University of Ottawa
    • Faculty of Medicine -
    • More details
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Study of the molecular pathogenesis and development of therapeutic approaches for myotonic dystrophy
    • The Cyprus Institute of Neurology and Genetics
    • Department of molecular genetics A
    • More details
    • FRANCE
    • AUVERGNE
    • CLERMONT-FERRAND
    • MYORES: Multi-organismic approach to study normal and aberrant muscle development, function and repair
    • Faculté de médecine de Clermont-Ferrand
    • Laboratoire de Génétique, Reproduction et Développement
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • EVRY
    • NMD-CHIP: design, production and technical validation of candidate genes targeted chips (WP3)
    • Généthon
    • Généthon - Banque d'ADN et de cellules
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • GARCHES
    • Tolerability and efficiency of the precoce use of non invasive nocturnal mechanical ventilation in adult affected by myotonic dystrophy
    • GHU Paris Ile-de-France Ouest - Hôpital Raymond Poincaré
    • Service de réanimation et unité de ventilation à domicile
    • More details
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Funded by an IRDiRC member
    • NEUROSPLICEDETAU: Implication and rescue of Tau mis-splicing in myotonique dystrophy
    • Faculté de médecine de Lille
    • Maladies neurodégénératives et mort neuronale
    • More details
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • NMD-CHIP: chip design, synthesis and technical validation for known genes involved in neuromuscular diseases (WP2)
    • CHU de Marseille - Hôpital de la Timone
    • Laboratoire de génétique moléculaire
    • More details
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • NICE
    • Study of proliferation and differentiation of myoblasts in muscular dystrophies
    • Faculté de médecine de Nice Sophia-Antipolis
    • Cellules souches et différenciation
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • BOCHUM
    • MYORES: analysis of the signalling pathways controlling hypaxial myogenesis in the avian embryo (2)
    • Ruhr-Universität Bochum
    • Institut für Anatomie
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • BOCHUM
    • MYORES: Identifizierung genetischer Defekte, die mit humanen Myopathien des Fetus assoziiert sind
    • Ruhr-Universität Bochum
    • Institut für Anatomie
    • More details
    • ITALY
    • LAZIO
    • ROMA
    • Development of an RNA interference-based system for the molecular cell therapy of Myotonic Dystrophy
    • Azienda Ospedaliera Universitaria Policlinico di Tor Vergata
    • U.O.C. Laboratorio di Genetica Medica
    • More details
    • ITALY
    • LAZIO
    • ROMA
    • Funded by an IRDiRC member
    • Role of autophagy in muscle diseases
    • IRCCS Ospedale Pediatrico Bambino Gesù
    • Unità di Malattie Neuromuscolari e Neurodegenerative, Laboratorio di Medicina Molecolare
    • More details
    • ITALY
    • LAZIO
    • ROMA
    • Characterization of pathways regulating cell cycle and muscle-specific transcription during myogenic differentiation: therapeutical implications for muscle regeneration
    • Parco Scientifico Biomedico di Roma San Raffaele
    • Laboratorio di Endocrinologia e Metabolismo Molecolare
    • More details
    • ITALY
    • LAZIO
    • ROMA
    • The RAMYD (risk of arrhythmias in Myotonc Dystrophy Type I) study: phase II
    • Università Cattolica del Sacro Cuore
    • Istituto di Anatomia Umana e Biologia Cellulare
    • More details
    • ITALY
    • LOMBARDIA
    • MONZA
    • Role of Necdin in the differentiation and regeneration of the skeletal muscle: mechanism of action and application to the cell therapy of muscular dystrophy
    • Consorzio per la Genetica Molecolare Umana
    • Dipartimento di Medicina Sperimentale
    • More details
    • ITALY
    • LOMBARDIA
    • SAN DONATO MILANESE
    • Validation of a neuromuscular individualized quality of life measure in Italy
    • IRCCS Policlinico San Donato
    • U.O. di Neurologia - Centro per lo Studio delle Malattie Neuromuscolari
    • More details
    • ITALY
    • VENETO
    • PADOVA
    • New mechanisms for the control of TGF-BETA/MYOSTATIN signaling in Muscular Dystrophy
    • CNR - Istituto di Neuroscienze
    • Dipartimento di Istologia Microbiologia e Biotecnologie Mediche
    • More details
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • McArm study: development of a motion controlled arm support
    • Radboudumc - Oost
    • Afdeling Revalidatie
    • More details
    • NETHERLANDS
    • Utrecht
    • UTRECHT
    • GMA - Group medical appointments for neuromuscular patients: To compare group medical appointments (shared medical appointments or group visits) with conventional one to one appointments for patients with a chronic neuromuscular disease in terms of health outcome (quality of life) and costs, an intervention study.
    • Piet van Dommelenhuis
    • CBO - Kwaliteitsinstituut voor de gezondheidszorg
    • More details
    • NETHERLANDS
    • Zuid-Holland
    • LEIDEN
    • GMA - Group medical appointments for neuromuscular patients: To compare group medical appointments (shared medical appointments or group visits) with conventional one to one appointments for patients with a chronic neuromuscular disease in terms of health outcome (quality of life) and costs, an intervention study.
    • LUMC - Leids Universitair Medisch Centrum
    • Afdeling Public Health en Eerstelijnsgeneeskunde
    • More details
    • SPAIN
    • Cataluña
    • BARCELONA
    • Development of new therapies for myotonic dystrophy: in vivo drug discovery (terminated)
    • Instituto Químico de Sarriá
    • Grupo de Ingeniería Molecular
    • More details
    • SPAIN
    • Cataluña
    • MOLLET DEL VALLÈS
    • Development of new therapies for myotonic dystrophy: in vivo drug discovery (terminated)
    • Institut Universitari de Ciència i Tecnologia
    • More details
    • SPAIN
    • Comunidad Valenciana
    • BURJASSOT
    • New therapeutic targets for myotonic dystrophy: analysis of microRNAs in two animal models of the disease
    • Universitat de València. Facultat de Ciencies Biologiques
    • Laboratorio de Genómica Traslacional
    • More details
    • SPAIN
    • Comunidad Valenciana
    • BURJASSOT
    • Development of new therapies for myotonic dystrophy: in vivo drug discovery (terminated)
    • Universitat de València. Facultat de Ciencies Biologiques
    • Laboratorio de Genómica Traslacional
    • More details
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • Funded by an IRDiRC member
    • NIHR BioResource - Rare Disease: SPEED - Specialist Pathology: Evaluating Exomes in Diagnostics
    • Wellcome Trust/MRC Building
    • Cambridge Institute for Medical Research
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • MYORES: analysis of the signaling pathways controlling hypaxial myogenesis in the avian embryo
    • Dental Institute - King's College London
    • Department of Cell & Developmental Biology
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • MYORES: comparison of the mechanisms regulating myogenic specification of trunk versus head muscles
    • Dental Institute - King's College London
    • Department of Cell & Developmental Biology
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Explaining and changing adverse illness perceptions in muscle disease by a cognitive behavioural therapy technique
    • Guy's Hospital
    • Health Psychology Section, Psychology Department, Institute of Psychiatry
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Study about the control of the efficiency of muscle regeneration and its implications in muscular dystrophies
    • School of Biomedical sciences - King's College London
    • Randall Division of Cell and Molecular Biophysics
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Relating satellite cell heterogeneity to stem cell function and its implications in muscular dystrophies
    • School of Biomedical sciences - King's College London
    • Randall Division of Cell and Molecular Biophysics
    • More details
    • UNITED KINGDOM
    • Lothian
    • EDINBURGH
    • Genetic disorders of human brain development
    • Western General Hospital
    • MRC Human Genetics Unit
    • More details
    • UNITED KINGDOM
    • Norfolk
    • NORWICH
    • MYORES: study epaxial myogenesis, role of Hedgehog and Wnt signalling in cell fate specification and the molecular basis of their known cooperativity, using animal models
    • University of East Anglia
    • School of biological sciences, cell and developmental biology
    • More details
    • UNITED KINGDOM
    • Nottinghamshire
    • NOTTINGHAM
    • Assays for drug discovery in myotonic dystrophy
    • Queen's Medical Centre
    • Human Genetics Group
    • More details
    • UNITED KINGDOM
    • Shropshire
    • OSWESTRY
    • A study of buccal cells in Myotonic Dystrophy
    • Robert Jones & Agnes Hunt Orthopaedic & District Hospital NHS Trust
    • The Centre for Inherited Neuromuscular Disorders
    • More details
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • MYORES: study epaxial myogenesis, role of Hedgehog and Wnt signalling in cell fate specification and the molecular basis of their known cooperativity, using animal models
    • University of Sheffield
    • Department of Biomedical Science
    • More details
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Long-term application of Poloxamer 188: A potential therapeutic agent in Muscular Dystrophy?
    • International Centre for Life
    • Institute of Genetic Medicine
    • More details
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (coordination)
    • International Centre for Life
    • Institute of Genetic Medicine
    • More details
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • NMD-CHIP: societal aspects of the development of targeted DNA-chips for high throughput diagnosis of neuromuscular disorders (WP7)
    • PEALS Research Centre, Newcastle University, 4th Floor
    • Policy, Ethics and Life Sciences (PEALS) Research Centre
    • More details
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • NIPSIGEN - Clinical translation of non-invasive prenatal diagnosis (NIPD) for single gene disorders (Health Innovation Challenge Fund)
    • Birmingham Women's NHS Foundation Trust
    • Regional Genetics Unit
    • More details